Eversept Partners
Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VERA, QQQ, GSK, UTHR, ABVX, and represent 32.10% of Eversept Partners's stock portfolio.
- Added to shares of these 10 stocks: ABVX (+$31M), SPY (+$31M), GSK (+$27M), AVTR (+$26M), EXAS (+$25M), CDTX (+$22M), BBNX (+$21M), TLT (+$20M), DHR (+$20M), GKOS (+$17M).
- Started 38 new stock positions in LLY, XBI, NVCR, BBNX, GKOS, EDIT, INMD, BHVN, TLT, EHAB.
- Reduced shares in these 10 stocks: NTRA (-$42M), ZIMV (-$39M), RVTY (-$22M), TEVA (-$22M), QURE (-$20M), RGEN (-$14M), RNA (-$13M), TECH (-$13M), NVO (-$12M), PCVX (-$10M).
- Sold out of its positions in ATYR, RNA, DYN, ETNB, GOSS, KRRO, KURA, MIRM, NKTR, NVO. PVLA, RGEN, REPL, Sutro Biopharma, ZIMV, MRUS.
- Eversept Partners was a net buyer of stock by $242M.
- Eversept Partners has $2.0B in assets under management (AUM), dropping by 36.76%.
- Central Index Key (CIK): 0001697013
Tip: Access up to 7 years of quarterly data
Positions held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eversept Partners
Eversept Partners holds 107 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Vera Therapeutics Cl A (VERA) | 7.8 | $156M | +9% | 3.1M | 50.64 |
|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 7.0 | $138M | -2% | 225k | 614.31 |
|
| GSK Sponsored Adr (GSK) | 6.6 | $131M | +26% | 2.7M | 49.04 |
|
| United Therapeutics Corporation (UTHR) | 6.2 | $123M | -6% | 253k | 487.25 |
|
| Abivax Sa Sponsored Ads (ABVX) | 4.5 | $89M | +54% | 658k | 134.85 |
|
| Natera (NTRA) | 3.9 | $77M | -35% | 335k | 229.09 |
|
| Syndax Pharmaceuticals (SNDX) | 3.5 | $70M | -4% | 3.3M | 21.01 |
|
| Miragen Therapeutics (VRDN) | 2.8 | $56M | -7% | 1.8M | 31.12 |
|
| Vaxcyte (PCVX) | 2.8 | $55M | -15% | 1.2M | 46.14 |
|
| Travere Therapeutics (TVTX) | 2.3 | $45M | -17% | 1.2M | 38.21 |
|
| Hca Holdings (HCA) | 2.3 | $45M | -14% | 96k | 466.86 |
|
| Danaher Corporation (DHR) | 2.1 | $43M | +87% | 186k | 228.92 |
|
| Ionis Pharmaceuticals (IONS) | 2.1 | $43M | 538k | 79.11 |
|
|
| Celldex Therapeutics Com New (CLDX) | 2.0 | $39M | +24% | 1.4M | 27.16 |
|
| Bruker Corporation (BRKR) | 1.9 | $37M | +14% | 784k | 47.11 |
|
| Avantor (AVTR) | 1.8 | $36M | +243% | 3.2M | 11.46 |
|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 1.5 | $31M | NEW | 45k | 681.92 |
|
| Community Health Systems (CYH) | 1.2 | $25M | +14% | 7.9M | 3.12 |
|
| EXACT Sciences Corporation (EXAS) | 1.2 | $25M | NEW | 242k | 101.56 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $23M | +117% | 3.0M | 7.80 |
|
| Geron Corporation (GERN) | 1.2 | $23M | +40% | 18M | 1.32 |
|
| Bio-techne Corporation (TECH) | 1.1 | $22M | -36% | 377k | 58.81 |
|
| Cidara Therapeutics Com New (CDTX) | 1.1 | $22M | NEW | 99k | 220.89 |
|
| Insulet Corporation (PODD) | 1.1 | $21M | +63% | 75k | 284.24 |
|
| Beta Bionics (BBNX) | 1.0 | $21M | NEW | 678k | 30.47 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.0 | $21M | -51% | 660k | 31.21 |
|
| UnitedHealth (UNH) | 1.0 | $20M | -3% | 61k | 330.11 |
|
| Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT) | 1.0 | $20M | NEW | 230k | 87.16 |
|
| Liquidia Corporation Com New (LQDA) | 0.9 | $18M | +4% | 509k | 34.49 |
|
| Icon SHS (ICLR) | 0.9 | $18M | +74% | 96k | 182.22 |
|
| Healthequity (HQY) | 0.9 | $17M | +254% | 186k | 91.61 |
|
| Glaukos (GKOS) | 0.8 | $17M | NEW | 148k | 112.91 |
|
| PerkinElmer (RVTY) | 0.8 | $16M | -58% | 163k | 96.75 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.7 | $15M | -13% | 421k | 35.08 |
|
| Esperion Therapeutics (ESPR) | 0.7 | $14M | NEW | 3.9M | 3.70 |
|
| Biogen Idec (BIIB) | 0.7 | $14M | +50% | 78k | 175.99 |
|
| Select Medical Holdings Corporation (SEM) | 0.7 | $14M | NEW | 906k | 14.85 |
|
| Centene Corporation (CNC) | 0.7 | $13M | +44% | 324k | 41.15 |
|
| Cg Oncology (CGON) | 0.6 | $13M | NEW | 309k | 41.52 |
|
| Bristol Myers Squibb (BMY) | 0.6 | $13M | NEW | 235k | 53.94 |
|
| Palisade Bio (PALI) | 0.6 | $13M | NEW | 5.4M | 2.35 |
|
| Arcutis Biotherapeutics (ARQT) | 0.6 | $13M | +289% | 435k | 29.04 |
|
| Pharvaris N V (PHVS) | 0.6 | $12M | NEW | 439k | 27.75 |
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 0.6 | $12M | NEW | 99k | 121.93 |
|
| Eli Lilly & Co. (LLY) | 0.6 | $11M | NEW | 11k | 1074.68 |
|
| Encompass Health Corp (EHC) | 0.6 | $11M | NEW | 107k | 106.14 |
|
| Cytomx Therapeutics (CTMX) | 0.5 | $11M | NEW | 2.5M | 4.26 |
|
| Anthem (ELV) | 0.5 | $11M | -32% | 30k | 350.55 |
|
| Mannkind Corp Com New (MNKD) | 0.5 | $11M | -9% | 1.9M | 5.67 |
|
| Xenon Pharmaceuticals (XENE) | 0.5 | $10M | NEW | 231k | 44.82 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.5 | $10M | NEW | 48k | 213.24 |
|
| Intuitive Surgical Com New (ISRG) | 0.5 | $10M | +25% | 18k | 566.36 |
|
| Illumina (ILMN) | 0.5 | $10M | -37% | 77k | 131.16 |
|
| Ardelyx (ARDX) | 0.5 | $10M | +19% | 1.7M | 5.83 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.5 | $9.3M | -12% | 606k | 15.38 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $8.9M | -23% | 128k | 69.55 |
|
| Edgewise Therapeutics (EWTX) | 0.4 | $8.4M | -32% | 337k | 24.82 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $8.4M | +2% | 358k | 23.34 |
|
| Humana (HUM) | 0.4 | $8.3M | +94% | 33k | 256.13 |
|
| Pennant Group (PNTG) | 0.4 | $8.3M | +673% | 294k | 28.15 |
|
| Moderna (MRNA) | 0.4 | $7.9M | NEW | 268k | 29.49 |
|
| Molina Healthcare (MOH) | 0.4 | $7.9M | +380% | 46k | 173.54 |
|
| Regeneron Pharmaceuticals (REGN) | 0.4 | $7.8M | -39% | 10k | 771.87 |
|
| Tyra Biosciences (TYRA) | 0.4 | $7.3M | +2% | 279k | 26.29 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.4 | $7.3M | NEW | 317k | 23.00 |
|
| Anaptysbio Inc Common (ANAB) | 0.3 | $5.9M | NEW | 121k | 48.48 |
|
| BioMarin Pharmaceutical (BMRN) | 0.3 | $5.6M | -36% | 94k | 59.43 |
|
| Assembly Biosciences Com New (ASMB) | 0.3 | $5.4M | NEW | 160k | 34.01 |
|
| Adagio Therapeutics (IVVD) | 0.3 | $5.3M | +4% | 2.1M | 2.47 |
|
| CVS Caremark Corporation (CVS) | 0.3 | $5.1M | NEW | 64k | 79.36 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $4.7M | +7% | 177k | 26.71 |
|
| Protagonist Therapeutics (PTGX) | 0.2 | $4.6M | NEW | 53k | 87.34 |
|
| Zenas Biopharma (ZBIO) | 0.2 | $4.4M | -23% | 121k | 36.31 |
|
| Relay Therapeutics (RLAY) | 0.2 | $4.1M | +2% | 489k | 8.46 |
|
| Engene Holdings (ENGN) | 0.2 | $4.1M | NEW | 456k | 9.03 |
|
| Brookdale Senior Living (BKD) | 0.2 | $4.0M | NEW | 375k | 10.79 |
|
| National HealthCare Corporation (NHC) | 0.2 | $3.9M | NEW | 29k | 137.09 |
|
| Fortrea Hldgs Common Stock (FTRE) | 0.2 | $3.9M | +2% | 224k | 17.25 |
|
| Bioventus Com Cl A (BVS) | 0.2 | $3.5M | +8% | 471k | 7.44 |
|
| Silverback Therapeutics (SPRY) | 0.1 | $2.9M | -74% | 252k | 11.65 |
|
| Anteris Technologies Global (AVR) | 0.1 | $2.5M | 500k | 4.99 |
|
|
| Amarin Corp Sponsored Adr (AMRN) | 0.1 | $2.4M | +2% | 172k | 13.96 |
|
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.1 | $2.3M | +147% | 719k | 3.25 |
|
| Evolus (EOLS) | 0.1 | $2.3M | -76% | 344k | 6.65 |
|
| Sutro Biopharma Com Shs (STRO) | 0.1 | $2.2M | NEW | 194k | 11.57 |
|
| Surrozen Com New (SRZN) | 0.1 | $2.2M | +23% | 95k | 22.60 |
|
| Enhabit Ord (EHAB) | 0.1 | $2.0M | NEW | 219k | 9.22 |
|
| Rapport Therapeutics (RAPP) | 0.1 | $1.8M | -58% | 59k | 30.34 |
|
| Inflarx Nv (IFRX) | 0.1 | $1.8M | 1.8M | 1.01 |
|
|
| Biohaven (BHVN) | 0.1 | $1.6M | NEW | 145k | 11.29 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $1.6M | +2% | 138k | 11.43 |
|
| Alector (ALEC) | 0.1 | $1.6M | -32% | 1.0M | 1.56 |
|
| Novocure Ord Shs (NVCR) | 0.1 | $1.6M | NEW | 121k | 12.93 |
|
| Uniqure Nv SHS (QURE) | 0.1 | $1.5M | -92% | 63k | 23.93 |
|
| Passage Bio Com New (PASG) | 0.1 | $1.5M | NEW | 126k | 11.80 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $1.3M | -7% | 179k | 7.08 |
|
| Novavax Com New (NVAX) | 0.1 | $1.2M | -25% | 181k | 6.72 |
|
| Pliant Therapeutics (PLRX) | 0.1 | $1.0M | +2% | 842k | 1.22 |
|
| Savara (SVRA) | 0.1 | $1.0M | NEW | 170k | 6.03 |
|
| eHealth (EHTH) | 0.1 | $1.0M | +73% | 223k | 4.60 |
|
| Inmode SHS (INMD) | 0.0 | $910k | NEW | 62k | 14.69 |
|
| Aadi Bioscience (WHWK) | 0.0 | $630k | NEW | 260k | 2.42 |
|
| Editas Medicine (EDIT) | 0.0 | $596k | NEW | 291k | 2.05 |
|
| Selectquote Ord (SLQT) | 0.0 | $504k | NEW | 358k | 1.41 |
|
| Retractable Technologies (RVP) | 0.0 | $449k | +59% | 581k | 0.77 |
|
| Ss Innovations International Com New (SSII) | 0.0 | $428k | NEW | 75k | 5.68 |
|
| Ceribell (CBLL) | 0.0 | $375k | 17k | 21.93 |
|
Past Filings by Eversept Partners
SEC 13F filings are viewable for Eversept Partners going back to 2017
- Eversept Partners 2025 Q4 filed Feb. 17, 2026
- Eversept Partners 2025 Q3 filed Nov. 14, 2025
- Eversept Partners 2025 Q2 filed Aug. 14, 2025
- Eversept Partners 2025 Q1 filed May 15, 2025
- Eversept Partners 2024 Q4 filed Feb. 14, 2025
- Eversept Partners 2024 Q3 filed Nov. 14, 2024
- Eversept Partners 2024 Q2 filed Aug. 14, 2024
- Eversept Partners 2024 Q1 filed May 15, 2024
- Eversept Partners 2023 Q4 filed Feb. 14, 2024
- Eversept Partners 2023 Q3 filed Nov. 14, 2023
- Eversept Partners 2017 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q1 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q2 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q3 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2019 Q1 restated filed Nov. 8, 2023